Psycopharm Text?

Started by DD214_DOC
Get help with your application

Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.

Browse articles Compare schools My application plan Read Interview Feedback
Practice for interviews Ask an Advisor
DD214_DOC

DD214_DOC

Full Member
Verified Member
Army
Physician
20+ Year Member
I'm an adult and pediatric psychiatrist. I would like to know what texts/books you PharmD guys would recommend to better my understanding of psychopharm. I get the impression our typical texts and references omit quite a few details, or aren't, "in depth" enough for my liking; this is particularly true for CNS stimulants. Any texts/references you guys would recommend?
 
Goodman & Gilmans (now 12th Ed.) has a really in depth CNS section; it's more science-y though....having wicked receptor affinity charts for CNS meds (domestic and international). Unfortunately, not too in depth on off-label use; I generally fill in the gaps with Lexicomp off-label & clinical pharmacology.

Got the look into Stahl's
 
beautifulrobot said:
Stahl's essential psychopharmacology is one of my favorite references, would highly recommend.
Click to expand...

Thanks. I have an older edition of Stahl's, but I haven't looked at it since residency. I will have to go back and check it out again to see if it has what I'm looking for. I see so much variability in the response and tolerability of what I prescribe, especially the CNS stimulants, and it bugs me that I don't have a great explanation, other than what I can reason out in my head.
 
DD214_DOC said:
Thanks. I have an older edition of Stahl's, but I haven't looked at it since residency. I will have to go back and check it out again to see if it has what I'm looking for. I see so much variability in the response and tolerability of what I prescribe, especially the CNS stimulants, and it bugs me that I don't have a great explanation, other than what I can reason out in my head.
Click to expand...

I wouldn't be surprised if genetics play some part in this variability. Hopefully as the field of pharmacogenomics expands, you may be able to get more in depth answers as to what is going on.
 
I recommend Stahl's firmly over Goodman and Gilman. G&G's coverage is very, very traditional and has a East Coast mentality in this area (if you follow the literature, there are still strong fundamental disagreements on representative models which G&G buries). The one that I wish was more recently updated, but the one that I was given for graduate introduction, was Schatzberg APA textbook (it's likely to be in your hospital's medical library and pass over the manual) as it went into some of the stronger details about the downsides and the problems with the current therapeutics uses particularly refractive therapy and has really good coverage of older medications (it's the best book for knowing the pre-atypical era drugs). I still have the APA 2002 book on my shelf to consult when we have a schizophrenic refractive to clozapine or someone that we can't figure out why their blood chemistries are so screwed up. The Goldberg is also handy when you're trying to troubleshoot therapy matters, but is less strong than Stahl or Schatzberg for underpinnings.
 
Last edited:
You must log in or register to reply here.